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Abstract
Background and methodology This study 
explored knowledge about human papillomavirus 
(HPV) and attitudes towards HPV vaccination 
among girls who were part of the ‘catch-up’ 
vaccination programme. Interviews were carried 
out between March and May 2009 with girls 
(aged 17–18 years) who had received HPV 
vaccine (n=5) and girls who had opted not to 
receive HPV vaccine (n=5). Interviews lasted 
approximately 25 minutes, were recorded and 
transcribed verbatim. The data were analysed 
qualitatively using framework analysis.
Results Most girls were aware that HPV is 
sexually transmitted, but beyond this had limited 
understanding of HPV and HPV vaccination, 
and expressed a desire for further information. 
Girls were uncertain about the need for the 
vaccine both in terms of perceived risk (e.g. 
because they were not sexually active) and 
because of its novelty. Some had concerns 
about the efﬁ cacy and safety of the vaccine, 
while others were mistrusting of the information 
provided. Being embarrassed about discussing 
the vaccine with parents and practical 
barriers to vaccination were also discussed.
Discussion and conclusions Understanding 
of HPV was poor, despite participants 
having been offered the vaccine. School-
based interventions might be a useful 
supplement to leaﬂ ets, and should focus on 
improving knowledge of HPV and awareness 
of the purpose of HPV vaccination.
Introduction
Human papillomavirus (HPV) vaccina-
tion is now available in the UK for girls 
in school Year 8 (aged 12–13 years). A 
one-off ‘catch-up’ programme has offered 
the vaccine to girls who were aged 14–18 
years old when the programme began. By 
September 2009, 88% of Year 8 girls had 
initiated the vaccination series,1 but ini-
tiation in the ‘catch-up’ cohort was much 
lower (62%). HPV is sexually transmitted2 
and the sexually transmitted nature of the 
virus may be more salient for girls in the 
‘catch-up’ group as they are likely to be 
closer to sexual debut than those in the 
main programme.
Little is known about HPV knowledge 
and attitudes among British girls aged over 
16 years who are expected to provide con-
sent for the vaccine themselves. This pilot 
study examined knowledge about HPV and 
attitudes towards HPV vaccination among 
girls in the ‘catch-up’ age range using 
qualitative methods. It was conducted to 
identify themes that may be important 
in girls’ vaccination decisions and would 
need exploring in a larger study.
Methods
Purposive sampling was used to recruit 
girls who had received at least one dose of 
the HPV vaccine (none had completed the 
series as the programme had just began) 
and girls who had opted not to receive the 
vaccine. All participants were aged 17–18 
years (Year 13) and had been offered the 
HPV vaccine as part of the ‘catch-up’ 
programme.
Recruitment occurred at a state further 
education college and a state school. In 
the college, students were approached by a 
researcher and invited to take part in face-
to-face interviews. Around 100 willing girls 
completed a demographics questionnaire 
(approximately 90 girls had begun the 
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Key message points
▶  Girls had limited knowledge of human papillomavirus 
(HPV) and HPV vaccination and appeared to be making 
uninformed decisions.
▶  Girls were uncertain about the need for vaccination, were 
concerned about its novelty and some mistrusted the 
information provided to them.
▶  Girls may beneﬁ t from school-based interventions to ensure 
that they can make informed decisions about having the 
HPV vaccination.
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vaccine course and 10 had opted not to receive the vac-
cine). Only one girl who had not received the vaccine 
agreed to be interviewed but five vaccinated girls were 
recruited. To fulfil our sample of unvaccinated girls, we 
approached a school that was able to identify five Year 
13 girls (out of approximately 90) who had not been 
vaccinated, four of whom agreed to be interviewed. 
These girls had been offered school-based vaccination 
whereas girls at the college had been invited to make an 
appointment with their general practitioner (GP).
Interviews lasting 15–30 minutes were carried out 
by one of the authors (KW) at the participants’ school 
or college between March and May 2009 and were 
structured around a topic guide adapted from a previ-
ous study.3 Girls were asked about their knowledge of 
cervical cancer and HPV, their own and friends’ expe-
riences of and attitudes towards the HPV vaccine, and 
their decision to have it or not. A topic guide was used 
to structure the interviews. This was developed by the 
authors using their previous experience of carrying 
out similar research with parents, and with reference 
to the literature from other countries on HPV vaccine 
decision-making in this age group.
Interviews were recorded and transcribed verba-
tim. Data were analysed using Framework Analysis, a 
matrix-based approach to organising qualitative data. 
The themes were decided upon based on discussion 
between all of the authors.
Results
The analysis focused on two main themes: knowledge 
about HPV and cervical cancer, and attitudes towards 
HPV vaccination. Participant demographics are pre-
sented in Table 1.
Knowledge about HPV and cervical cancer
Overall, girls’ knowledge of HPV was surprisingly lim-
ited given that they had all been offered the vaccine 
and most had received an information leaflet. As the 
vaccine is being promoted as a cervical cancer vaccine, 
some had not even heard of HPV. Those who had heard 
of HPV did not know much about it, and there was 
poor understanding of the causal link between HPV 
and cervical cancer. However, when prompted about 
the link between HPV and cervical cancer, some girls 
were able to remember basic details about it. Several 
girls were aware that the HPV vaccine should be given 
prior to sexual debut, although some thought this 
meant they should not have sex between each dose. 
Some held misconceptions about the protective effect 
of condoms and for that reason had a low perceived 
risk of HPV: “I’m not in a rush to get it because I don’t 
have as many sexual partners or anything like that. I 
use protection” (NV10). [NB. Participant ID numbers 
distinguish between those who had been vaccinated 
(V) and those who had not (NV)]. Girls did not con-
sider their lack of knowledge to be unusual; one girl 
mentioned that her friend had misconceptions about 
who the vaccine was for: “my friend kept saying that 
it’s for people who have promiscuous sex” (V5).
Some did not understand the need for the vaccine: “I 
don’t really know why suddenly they want us to have 
it [the HPV vaccine]. If people have never had it, like 
why introduce a new jab? I don’t understand” (NV8). 
Furthermore, regardless of vaccine status, the girls did 
not think that they were at high risk of getting cervical 
cancer and certainly not at a greater risk than anyone 
else. Only one girl related her perceived risk of cervical 
cancer to having the HPV vaccine. She said: “I never 
really felt at risk but I think having it [the HPV vac-
cine] makes me feel more protected” (V3).
Desire for information
Most girls had received a leaflet about HPV and the 
vaccine when they were invited to have the vaccine. 
Several girls had also done their own research and 
some had seen stories about the HPV vaccine on the 
news, posters or adverts on TV. However many did not 
feel they had been given enough information to make 
an informed decision: “there was no number or email 
address. I wanted to get information on it but I wanted, 
like, a proper booklet that I could read through” (NV9). 
Table 1 Sample characteristics
Participant number* Age (years) HPV vaccinated? Where was the vaccine offered? Nationality/ethnicity Religion
V1 17 Yes (2 doses) GP British Asian Muslim
V2 17 Yes (2 doses) GP White British None
V3 17 Yes (2 doses) GP White British None
V4 17 Yes (2 doses) GP White British None
V5 18 Yes (2 doses) GP British Asian Muslim
NV6 18 No School White British None
NV7 17 Only 1 dose† School White British None
NV8 18 No School White British None
NV9 18 No School White British None
NV10 18 No GP White British None
*Participant ID numbers indicate whether girls had been vaccinated (V) or not vaccinated (NV).
†Not intending to complete the course.
GP, general practitioner; HPV, human papillomavirus.
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Another girl felt that the leaflet was a “patronising little 
bit of information” (NV10). Almost all of these girls said 
that they would like to have been given information on 
the vaccine in school. For example, one girl suggested 
that it would be useful to have “a lesson or like 15 min-
utes in assembly” (NV7). Another girl said she thought 
the school should “hold compulsory workshops” (V1).
Attitudes towards HPV vaccination
Five subthemes emerged relating to girls’ attitudes 
towards HPV vaccination: (1) peers’ opinions, (2) 
deciding to have the vaccine and discussing it with 
others, (3) practical issues, (4) issues relating to sexual 
behaviour and (5) safety and efficacy of the vaccine.
Peers’ opinions
Several girls had friends who had raised concerns 
about the HPV vaccine. This was mainly because of a 
fear of needles and having to have three doses; how-
ever, one girl mentioned that her friend was concerned 
about the safety of the vaccine. Most felt that their 
friends were happy to have the vaccine and believed 
that having the vaccine was the norm. Some girls, par-
ticularly those who had not had the vaccine said that 
they knew people who did not want it. For example, 
one girl said some people did not see the point of hav-
ing the vaccine if it only protects against one type of 
cancer. Another girl who had not had the HPV vaccine 
said that a lot of her friends did not want the vaccine 
but were having it because their parents wanted them 
to: “it was more like, ‘oh, my parents think I should 
have it so that’s why I’m having it. I really don’t want 
to have it’” (NV10).
Deciding to have the vaccine and discussing it 
with others
All of the girls said they made their own decision about 
whether or not to have the HPV vaccine. For those 
who had received it, their main reason was protection 
against cancer. Most girls had discussed the vaccine 
with others. Some reported that their mothers encour-
aged them to have the vaccine whereas other parents 
were less positive. One girl reported that her mother 
had concerns but was more positive after she had 
researched it herself (V3).
Issues relating to HPV and sexual behaviour
Most girls felt that the sexually transmitted nature of 
HPV was not relevant to their attitudes, for example 
one girl said that: “More people focused on the cancer 
things rather than the STIs” (V3). However, one girl 
thought that this link could be more of an issue for 
younger girls because it might imply that they are hav-
ing sex at a young age: “… people might think ‘oh, why 
are you getting it done then?’ and then questions will 
be asked” (NV6).
The issue of embarrassment was raised, in relation to 
the vaccine being for a sexually transmitted infection. 
One girl thought that some people might be embar-
rassed going to have the vaccine. Another said she was 
too embarrassed to talk about the vaccine with her 
father.
When prompted, most girls did not think that the 
HPV vaccine would encourage risky sexual behaviour. 
However, the opinion was expressed that some girls 
would “definitely feel they’re more protected. Like, 
they won’t be as worried because they’ll feel they’ve 
had the jab, they’ve got a bit of protection” (V5).
Safety and efficacy of the vaccine
The majority of girls who had opted not to have the 
HPV vaccine had concerns about its novelty, efficacy 
and safety. For example, one girl felt that there was no 
evidence of the vaccine’s efficacy and there was some 
mistrust of the information provided: “they fail to men-
tion some certain side effects” (NV10). One girl who 
had received the vaccine also expressed concern about 
the vaccine’s safety, suggesting that there were “major 
things that could go wrong in a few years’ time” (V3).
Practical issues
Some girls who had received the vaccine highlighted 
practical issues. For example, one girl mentioned that 
she “had … to take a couple of lessons off so [she] could 
go” (V3). However, in general none of them found 
these issues particularly problematic. In contrast, one 
girl (NV7) had received her first dose of the vaccine 
in school but was ill when the vaccination team came 
to administer the second dose. This girl did not pri-
oritise arranging the second dose through her GP and 
consequently did not believe that she would finish the 
vaccination course.
Discussion
This small pilot study explored knowledge of HPV 
and attitudes towards HPV vaccination among girls in 
the first year of the HPV vaccination ‘catch-up’ pro-
gramme who had started their HPV vaccination course 
or had opted not to receive it.
Knowledge of HPV and the HPV vaccine was limited, 
with some girls knowing nothing and few understanding 
the relationship between HPV and cervical cancer. This 
finding is reflective of the experience in adolescent vac-
cination generally,4 although it is still surprising, as most 
girls in this study had received information about HPV. 
Simply providing a leaflet about the vaccine appears not 
to be sufficient to ensure HPV knowledge. This is con-
cerning because good knowledge is a prerequisite for 
informed choice.5 Furthermore, vaccinated girls who 
have misunderstood the purpose of the vaccine may 
engage in more risky sexual behaviour. There was unani-
mous agreement about the need for education sessions.
Some unvaccinated girls had misconceptions about 
the link between HPV and sexual behaviour and did 
not perceive a need for vaccination, or believed that 
they were at low risk of cervical cancer or HPV. Most 
girls did not think they would change their sexual 
behaviour as a result of having the vaccine, but they 
believed others might do this and some felt that talking 
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about it could be embarrassing. Another reason for 
non-acceptance was concern about side effects.
Some participants were mistrusting of the informa-
tion provided to them and believed that negative con-
sequences of vaccination were being withheld. Parents’ 
hesitations were reported, but social norms also pro-
moted uptake. This demonstrates that even though 
these girls could provide consent themselves, they were 
still influenced by their parents’ and others’ opinions.
These findings are based on a small sample and all 
participants were in full-time education. It is likely that 
attitudes and barriers may differ from those who are 
not studying. Nevertheless, the findings highlight areas 
for further study.
In summary, both vaccinated and unvaccinated girls 
had a poor understanding of HPV and the HPV vaccine 
and wanted further information. School-based interven-
tions could supplement information leaflets to ensure 
that vaccination decisions are informed and should focus 
on improving knowledge of HPV and raising awareness 
of the efficacy and safety of HPV vaccination.
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